Tcrx Therapeutics Co.ltd
Clinical trials sponsored by Tcrx Therapeutics Co.ltd, explained in plain language.
-
New personalized cell therapy targets tough cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a personalized treatment called KXV01 TCR Lentinvivo for people with advanced solid tumors that have not responded to standard therapies. The therapy uses a patient's own immune cells, modified to better recognize and attack cancer. The main goals are…
Phase: PHASE1 • Sponsor: TCRx Therapeutics Co.Ltd • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New gene therapy targets advanced tumors in early trial
Disease control Not yet recruitingThis early-phase study tests a new treatment called KXV01 TCR Lentinvivo for people with advanced solid tumors that have not responded to standard therapies. The main goal is to check safety and find the right dose. About 30 adults aged 18 to 70 will receive a single infusion and…
Phase: PHASE1 • Sponsor: TCRx Therapeutics Co.Ltd • Aim: Disease control
Last updated May 13, 2026 16:02 UTC